Your trusted source for investing success

Tag: cannabis

Valens issues 322,221 shares from warrant exercise

Valens issues 322,221 shares from warrant exercise

Valens GroWorks Corp. (CSE:VGW) (the “Company” or “Valens”) is pleased to announce the exercise of 322,221 warrants at a price of $0.75 per share, resulting in the issue of 322,221 common shares of the Company. This provides $41,666 cash added to the Company’s treasury, and a $200,000 reduction in payables.

PUF Ventures Enters Partnership with MYM Nutraceuticals to Build One Million Square Foot Cannabis Production Facility in Australia

PUF Ventures Enters Partnership with MYM Nutraceuticals to Build One Million Square Foot Cannabis Production Facility in Australia

PUF Ventures Inc. (“PUF” or the “Company”) (CSE: PUF) (Frankfurt: PU3) (OTCPK: PUFXF), an advanced Access to Cannabis for Medical Purposes Regulations (“ACMPR”) license applicant, is pleased to announce that it has entered into a strategic partnership with MYM Nutraceuticals Inc. (CSE:MYM) (OTC:MYMMF) (“MYM”) for the construction of a one million square foot

Harvest One Responds to TSX Announcement in Relation to U.S. Assets

Harvest One Responds to TSX Announcement in Relation to U.S. Assets

Harvest One Cannabis Inc. (TSXV:HVST) (“Harvest One” or the “Company”) would like to provide clarification to shareholders in relation to both the Canadian Securities Administrators (“CSA”) staff notice 51-352 — Issuers with U.S. Marijuana-Related Activities and the Toronto Stock Exchange (“TSX”) guidance on Section 306, Section 325 and Part VII

Invictus MD Updates Shareholders on Cannabis Legalization Process

Invictus MD Updates Shareholders on Cannabis Legalization Process

Invictus MD Strategies (“Invictus MD” or the “Company”) (TSXV: IMH; OTC: IVITF; FRA: 8IS1) Today, Invictus MD updated shareholders that it is taking steps to monitor the government policy development process in advance of the legalization of recreational cannabis that is expected in July 2018.

“There are a number of authorities across the

FREE Report - How Will Trump Affect Your Gold Investments? 

Trump’s policies are affecting gold. You should know what’s going on. Click here to get our FREE report.

Click here to get your free report!

Discover what the experts see coming in the Age of Trump with our INN Insider's Report free of charge! Includes expert insights into Trump and his effect on mining and gold.

 
Enter Your Log In Credentials
This setting should only be used on your home or work computer.

×

Privacy & Legal Policy

Privacy Policy

×
Investing News Network

Send this to a friend

Hi,
I thought you might find this interesting:
5 Top NASDAQ Biotech Stocks: Aevi Genomic Takes the Lead

URL: https://investingnews.com/daily/life-science-investing/biotech-investing/weekly-top-nasdaq-biotech-stocks/